NCT02817633 2025-10-28A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)Tesaro, Inc.Phase 1 Active not recruiting463 enrolled
NCT04306900 2025-07-29TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced CancersTrishula Therapeutics, Inc.Phase 1 Completed185 enrolled 28 charts
NCT04553692 2025-03-28Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed CancersIGM Biosciences, Inc.Phase 1 Terminated272 enrolled
NCT05084859 2024-08-09A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid TumorsBiosplice Therapeutics, Inc.Phase 1 Terminated30 enrolled
NCT02740985 2023-05-26A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid MalignanciesAstraZenecaPhase 1 Completed313 enrolled
NCT00288444 2012-12-18Interaction of Docetaxel and Lonafarnib in Patients With Advanced CancerEmory UniversityPhase 1 Terminated38 enrolled